Home/Filings/4/0001209191-09-036120
4//SEC Filing

LESCHLY JAN 4

Accession 0001209191-09-036120

CIK 0001103021other

Filed

Jul 8, 8:00 PM ET

Accepted

Jul 9, 4:22 PM ET

Size

27.7 KB

Accession

0001209191-09-036120

Insider Transaction Report

Form 4
Period: 2009-07-07
Transactions
  • Sale

    Common Stock

    2009-07-07$6.12/sh13,158$80,584159,405 total(indirect: See footnote:)
  • Sale

    Common Stock

    2009-07-08$6.25/sh261$1,631159,144 total(indirect: See footnote:)
LESCHLY JAN
10% Owner
Transactions
  • Sale

    Common Stock

    2009-07-07$6.12/sh13,158$80,584159,405 total(indirect: See footnote:)
  • Sale

    Common Stock

    2009-07-08$6.25/sh261$1,631159,144 total(indirect: See footnote:)
Transactions
  • Sale

    Common Stock

    2009-07-08$6.25/sh261$1,631159,144 total(indirect: See footnote:)
  • Sale

    Common Stock

    2009-07-07$6.12/sh13,158$80,584159,405 total(indirect: See footnote:)
Transactions
  • Sale

    Common Stock

    2009-07-07$6.12/sh13,158$80,584159,405 total(indirect: See footnote:)
  • Sale

    Common Stock

    2009-07-08$6.25/sh261$1,631159,144 total(indirect: See footnote:)
CDC IV LLC
10% Owner
Transactions
  • Sale

    Common Stock

    2009-07-07$6.12/sh13,158$80,584159,405 total(indirect: See footnote:)
  • Sale

    Common Stock

    2009-07-08$6.25/sh261$1,631159,144 total(indirect: See footnote:)
Footnotes (2)
  • [F1]On July 7, 2009, CDC IV, LLC sold an aggregate of 13,158 shares of Common Stock of BioDelivery Sciences International, Inc. at an average gross price per share of $6.1243. The individual trades made by CDC IV, LLC on July 7, 2009 are set forth on Exhibit 1 attached hereto.
  • [F2]The reportable securities are owned directly by CDC IV, LLC and indirectly by CDC Operations LLC, David R. Ramsay, Argeris Karabelas and Jan Leschly. CDC Operations LLC disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that CDC Operations LLC is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of its pecuniary interest therein. David R. Ramsay, Argeris Karabelas and Jan Leschly are each partners of CDC Operations LLC. Messrs. Ramsay, Karabelas and Leschly each disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that Messrs. Ramsay, Karabelas and Leschly is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their pecuniary interest therein.

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeother

Related Parties

1
  • filerCIK 0001204568

Filing Metadata

Form type
4
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:22 PM ET
Size
27.7 KB